Top Markets
Coin of the day
Novo Integrated Sciences, Inc. Novo Integrated Sciences, Inc.

Novo Integrated Sciences, Inc.

NVOS
Clasificación en acciones #41581
Novo Integrated Sciences, Inc. (NVOS) delivers a diverse array of primary... Novo Integrated Sciences, Inc. (NVOS) delivers a diverse array of primary healthcare services and related products through its two primary operational segments: Healthcare Services and Product Manufacturing and Development. The company's extensive service portfolio includes various therapeutic approaches such as physiotherapy, chiropractic care, manual manipulation, occupational therapy, and massage therapy. They also offer specialized treatments like acupuncture, functional dry needling, chiropody, and advanced rehabilitation for stroke, traumatic brain injuries, and other neurological conditions. Additionally, NVOS provides kinesiology, vestibular therapy, concussion management, and baseline testing, alongside unique programs like trauma-sensitive yoga and meditation for brain injury recovery and PTSD. Women's pelvic health, sports medicine, assistive device provision, dietetics, holistic nutrition, fall prevention education, sports team conditioning, and private personal training are also part of their offerings. Novo Integrated Sciences, Inc. is dedicated to the assessment, diagnosis, treatment, pain management, rehabilitation, education, and prevention of a wide range of orthopedic, musculoskeletal, sports injury, and neurological conditions. These services are provided across all age demographics, from pediatric and adult patients to geriatric populations. For older adults, the company offers comprehensive eldercare physiotherapy within long-term care homes, retirement communities, and through community-based home care. This includes group exercise classes and fall prevention initiatives, alongside services at outpatient clinics. Similarly, occupational therapy services for the elderly are extended to retirement communities and long-term care facilities. Beyond direct care, the company incorporates medical technology, offering telemedicine consultations and remote patient monitoring. It also actively develops and distributes bespoke health and wellness product solutions. NVOS operates a network of 16 wholly-owned clinics. Established in 2000, the company is headquartered in Bellevue, Washington, and operates as a subsidiary of ALMC-ASAP Holdings, Inc.
Precio por acción
$0.0008
Última sincronización: 2026-08-12
Capitalización bursátil
$15.78K
Cambio (1 día)
-77.14%
Cambio (1 año)
-11.11%
País
US
Comercio Novo Integrated Sciences, Inc. (NVOS)

Categoría

Ratio P/E de Novo Integrated Sciences, Inc. (NVOS)
Ratio P/E al 2026 TTM: 0
Según los últimos informes financieros y el precio de las acciones de Novo Integrated Sciences, Inc., el P/E actual (TTM) de la empresa es 0. Al final de 2026, la empresa tenía un P/E de 0.
Historial del ratio P/E de Novo Integrated Sciences, Inc. desde 2026 hasta 2026
Relación P/E al final de cada año
Año Ratio P/E Cambiar
Not enough data for the provided dates.
Relación P/E para empresas similares o competidores
¿Cómo leer un P/E ratio?

El ratio Precio/Beneficio (P/E Ratio) mide la relación entre el precio de las acciones de una empresa y sus beneficios por acción.
Un P/E bajo pero positivo indica una empresa con altos beneficios en relación a su valoración actual y que podría estar infravalorada. Una empresa con un P/E negativo alto (cerca de 0) indica fuertes pérdidas en comparación con su valoración.

Las empresas con un P/E superior a 30 o negativo suelen considerarse "acciones de crecimiento", lo que significa que los inversores esperan que crezca o se vuelva rentable en el futuro.

Las empresas con un P/E positivo inferior a 10 suelen considerarse "acciones de valor", lo que significa que ya son muy rentables y no se espera un fuerte crecimiento.